MIH
IBBQ icon

Meitav Investment House’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Meitav Investment House’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-880
Closed -$17.8K – 417
2023
Q2 		$17.8K Buy
+880
New +$18.4K ﹤0.01% 506

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Meitav Investment House's IBBQ Position: Q3 2023 in Review

Meitav Investment House sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q3 2023, closing a stake of 880 shares — an estimated $17.8K sold.

Meitav Investment House first reported a position in IBBQ in Q2 2023 and held it in 1 quarter. The position peaked at $17.8K in Q2 2023. 13 funds tracked by Wall St. Rank hold IBBQ as of Q3 2023.

  • Meitav Investment House reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • Meitav Investment House sold 880 Invesco NASDAQ Biotechnology ETF shares in Q3 2023, an estimated $17.8K.
  • Meitav Investment House first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2023 and held it in 1 quarter.
  • Meitav Investment House's Invesco NASDAQ Biotechnology ETF position peaked at $17.8K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2023.

Based on Meitav Investment House's 13F filing for Q3 2023, filed 30 Oct 2023.